Show Notes
Part 3 of 3: My guest for this week’s episode is Mike Stadnisky, Managing Director of Thielsen Capital. Thielsen Capital is a seed-stage financing syndicate network bringing together life science investors, operators, and innovators to drive exceptional outcomes for founding teams, investors, and science. Before Thielsen, Mike was the CEO of Phitonex, which Thermo Fisher acquired. He was also VP & GM of Informatics at BD Life Sciences and was the CEO of FlowJo before its acquisition by BD. He has also taught at MIT Sloan, authored 10 patents, and won the 2019 International Society for the Advancement of Cytometry Innovation Award.
Join us as we conclude our conversation with Mike Stadnisky as he discusses the important lessons that he learned from going through the M&A process, and how knowing about them early can benefit founders. We also discuss why it is essential for you to have the mentality that someone will see your corporate “underwear,” and why proper documentation is tedious yet vital to your company’s success. Finally, we conclude our interview with Mike by reviewing Thielsen Capital’s unique investment philosophy and the exciting things that are on the horizon for them. Please enjoy my conversation with Mike Stadnisky.
Resources & Articles
Thielsen Capital https://www.thielsencapital.com/
FlowJo Inc. https://www.flowjo.com/
Phitonex https://www.linkedin.com/company/thermospectralcytometry/
Levi’s https://www.levistrauss.com/levis-history/
How Do Core Labs Support Life Science Research? https://www.excedr.com/blog/core-labs/
Top Cities for Biotech https://www.excedr.com/blog/top-cities-for-biotech/
What Should Investors & Founders Expect From Each Other? https://www.excedr.com/resources/investor-founder-expectations/
What is Financial Modeling https://www.excedr.com/resources/what-is-financial-modeling
Software Tools for Keeping Startup Costs in Check https://www.excedr.com/blog/tools-for-keeping-startup-costs-in-check
Guide to Reducing Startup Costs & Expenses https://www.excedr.com/blog/startup-costs-and-expenses
What Is Equity Crowdfunding https://www.excedr.com/resources/equity-crowdfunding-in-biotech
How to get Funding for Lab Research https://www.excedr.com/blog/how-to-get-funding-for-lab-research
Guide to Grant Funding for Biotech Startups https://www.excedr.com/resources/grants-public-funding-biotech-startups
Biotech Startup Funding Options https://www.excedr.com/resources/biotech-startup-funding-options
VC Term Sheets: What They Include & Why They Matter https://www.excedr.com/resources/venture-capital-term-sheets/
Multi-Omics https://en.wikipedia.org/wiki/Multiomics
Ultrarunning https://en.wikipedia.org/wiki/Ultramarathon
Term sheets https://www.investopedia.com/terms/t/termsheet.asp
Mergers and Acquisitions (M&A) https://www.investopedia.com/terms/m/mergersandacquisitions.asp
Business Development https://www.investopedia.com/articles/personal-finance/090815/basics-business-development.asp
Decision-Makers vs. Technical Champions https://www.linkedin.com/pulse/champion-vs-decision-maker-whom-target-b2b-customer-frederik-vosberg/
What are KOLs
https://www.linkedin.com/pulse/what-kol-marketing-key-opinion-leaders-retailboss/
Go-to-Market Strategy https://www.cognism.com/blog/what-is-a-go-to-market-strategy
Organizations & People
Mario Roederer https://www.flowjo.com/about/company/founders
Alex Roederer https://www.linkedin.com/in/alex-roederer-8562051b9/
Alvin Phitonex https://www.linkedin.com/in/alvin-lebeck-b626842/
Craig LaBonda https://www.linkedin.com/in/craiglaboda/